Birnbaum, Daniel, 1953-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Daniel Birnbaum researcher
VIAF ID: 264946561 (Personal)
Permalink: http://viaf.org/viaf/264946561
Preferred Forms
-
200 _ | ‡a Birnbaum ‡b Daniel ‡f 1953-....
-
100 1 _
‡a
Birnbaum, Daniel,
‡d
1953-
-
100 1 _ ‡a Birnbaum, Daniel, ‡d 1953-
-
100 1 _ ‡a Birnbaum, Daniel, ‡d 1953-
-
100 1 _
‡a
Birnbaum, Daniel,
‡d
1953- ..
-
100 1 _
‡a
Birnbaum, Daniel,
‡d
1953-....
-
100 0 _
‡a
Daniel Birnbaum
‡c
researcher
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| Ainsi futiles |
|
| Anomalies du centrosome et oncogenèse |
|
| Apport de l'étude des altérations moléculaires en cancérologie |
|
| Bien plus petits que toi |
|
| Caractérisation de nouvelles séquences transformantes humaines : structure moléculaire, mécanisme d'activation : contribution à l'étude des oncogènes humains |
|
| Caractérisation d'un recepteur à tyrosine kinase apparenté à KIT et FMS |
|
| cercueil à deux places |
|
| Characterization of five discrete chromosomal regions frequently amplified in breast cancers. |
|
| Characterization of genetic and epigenetic changes associated to early steps of mammary tumor transformation. |
|
| À chute ou abruptes 85 textes courts |
|
| The colour of shadow, [2019]: |
|
| Contribution à l'étude de l'activité in vitro de la rifamycine SV |
|
| Contribution of studying molecular alterations in oncology. |
|
| Le début de la vague |
|
| Dérèglements de contes : recueil de haïbuns et tanka-prose |
|
| Épris de court |
|
| espace commence au bord de la fenêtre |
|
| Etude des mécanismes cellulaires de transduction de signaux, à travers la caractérisation de deux gènes : le proto-oncogène MCF2/DBL et le gène FLT4 |
|
| Fenêtres |
|
| fil des jours nouvelles |
|
| FUNCTIONAL CHARACTERIZATION OF FLT4/VEGFR3 ISOFORMS, A RECEPTOR WITH TYROSINE KINASE ACTIVITY. |
|
| Gene expression profiling in breast cancer : DNA arrays. |
|
| Genetic and functionnal studies of two molecules involved in cellular communication : FGF6, fibroblast growth factor and CBL3 a new E3-ligase. |
|
| The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer |
|
| Implication of checkpoint kinase 1 protein in cell cycle regulation of epithelial mammary cells and its role in drugs response. |
|
| Isolation and characterization of oncogenes from human tumors. |
|
| Isolement et caractérisation d'oncogènes issus de tumeurs humaines |
|
| The LAP family: a phylogenetic point of view |
|
| lutte finale ? de l'oncologie moléculaire à la médecine personnalisée à travers le parcours d'un chercheur |
|
| MARCKS protein overexpression is associated with poor prognosis in male breast cancer |
|
| Mesure d'expression génique dans le cancer du sein : Puces à ADN |
|
| Minitudes haïkus, senryus, aphorismes, tercets divers |
|
| MISE EN EVIDENCE DE FACTEURS PRONOSTIQUES ET PREDICTIFS DANS LE CANCER DU SEIN |
|
| Mise en place et utilisation des faisceaux FFF en radiothérapie : radiobiologie, caractérisation physique, contrôles qualité, modélisation et planification de traitement |
|
| Molecular characterization of myeloproliferative neoplasms non-Chronic Myeloid Leukemia. |
|
| Molecular complexes associated with Aurora kinases during mitotic progression : TACC and Ajuba. |
|
| Monde, j'aime ce monde |
|
| A pair as a minimum: the two fibroblast growth factors of the nematode Caenorhabditis elegans |
|
| Le passé inaperçu : 98 poèmes inspirés du tanka |
|
| The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers |
|
| Petits fils éclectiques |
|
| poupée effacée nouvelle |
|
| Prognostic and predictive factors for primary breast cancer. |
|
| ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2 |
|
| Puces à ADN en cancérologie principes et utilisations |
|
| Quand je serai jeune |
|
| Re: Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers |
|
| Régulation de la signalisation du récepteur à l'EGF [Epidermal Growth Factor] par les E3 ligases Cbl-c & AIP4/Itch |
|
| Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes |
|
| The role of menin in prostate and breast cancers. |
|
| Sensitive and easy screening for circulating tumor cells by flow cytometry |
|
| SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias. |
|
| Si Dieu me voit, c'est qu'il a du temps à perdre nouvelle |
|
| SPAG5: the ultimate marker of proliferation in early breast cancer? |
|
| [Stem cells and epithelial cancers: the example of breast cancer] |
|
| Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value. |
|
| Structural studies and mechanism of activation of human transforming sequences: characterization of a new member of the fibroplast growth factor family. |
|
| Study of circulating tumor cells as blood biomarkers representative of solid tumors. |
|
| suivi de Mouettes mouettes |
|
| Sur des brumes incertaines |
|
| TACC-TIC cellulaires |
|
| Targeted molecular characterization shows differences between primary and secondary myelofibrosis |
|
| Taxonomie moléculaire des cancers du sein |
|
| temps mauve |
|
| The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype |
|
| Tout va de trois vers |
|
| Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma |
|
| Tyrosine kinases oncogéniques dans les syndromes myéloprolifératifs et signalisation centrosomale |
|
| Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets |
|
| Validation and comparison of the molecular classifications of pancreatic carcinomas |
|
| Validation of an immunohistochemical signature predictive of 8-year outcome for patients with breast carcinoma. |
|
| Wandering roots |
|
| What drives breast cancer heterogeneity: oncogenic events or cell of origin? |
|
| Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas-Letter |
|
| XPO1, therapeutic … and prognostic target in sarcomas |
|
| ZNF703gene amplification at 8p12 specifies luminal B breast cancer |
|
